塞替匹仑 T3520
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 866460-33-5 | ¥328.00 | 询底价 |
100 mg | 866460-33-5 | ¥1,430.00 | 询底价 |
5 mg | 866460-33-5 | ¥228.00 | 询底价 |
1 mL | 866460-33-5 | ¥253.00 | 询底价 |
25 mg | 866460-33-5 | ¥597.00 | 询底价 |
200 mg | 866460-33-5 | ¥2,130.00 | 询底价 |
50 mg | 866460-33-5 | ¥963.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Setipiprant
描述: Setipiprant (ACT-129968) 是一种口服的选择性 CRTH2 拮抗剂,IC50为6.0 nM。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 36 mg/mL
关键字: rhinitis | KYTH 105 | selective | Prostaglandin Receptor | Setipiprant | calcium liberation | Inhibitor | dog | HEK-293 | cAMP | asthma | KYTH105 | oral | ACT 129968 | ACT129968 | inhibit | rat
相关产品: DJ-V-159 | NF-56-EJ40 | GPR40/FFAR1 modulator 1 | Palosuran hydrochloride 540769-28-6(free base) | Urotensin II, mouse TFA (9047-55-6 free base) | GPR120 Agonist 3 | GPR84 antagonist 8 | AZD1981 | MCH(human, mouse, rat) | GSK256073
相关库: Drug Repurposing Compound Library | ReFRAME Related Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Anti-Cancer Clinical Compound Library | GPCR Compound Library | Target-Focused Phenotypic Screening Library | Bioactive Compound Library
塞替匹仑 T3520信息由TargetMol中国为您提供,如您想了解更多关于塞替匹仑 T3520报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途